Pediatric Reports (Sep 2023)

BoDV-1 Infection in Children and Adolescents: A Systematic Review and Meta-Analysis

  • Matteo Riccò,
  • Ilaria Zanella,
  • Elia Satta,
  • Silvia Ranzieri,
  • Silvia Corrado,
  • Federico Marchesi,
  • Simona Peruzzi

DOI
https://doi.org/10.3390/pediatric15030047
Journal volume & issue
Vol. 15, no. 3
pp. 512 – 531

Abstract

Read online

Borna disease virus 1 (BoDV-1) can cause a severe human syndrome characterized by meningo-myeloencephalitis. The actual epidemiology of BoDV-1 remains disputed, and our study summarized prevalence data among children and adolescents (<18-year-old). Through systematic research on three databases (PubMed, EMBASE, MedRxiv), all studies, including seroprevalence rates for BoDV-1 antigens and specific antibodies, were retrieved, and their results were summarized. We identified a total of six studies for a total of 2692 subjects aged less than 18 years (351 subjects sampled for BoDV-1 antibodies and 2557 for antigens). A pooled seroprevalence of 6.09% (95% Confidence Interval [95% CI] 2.14 to 16.17) was eventually calculated for BoDV-1 targeting antibodies and 0.76% (95% CI 0.26 to 2.19) for BoDV-1 antigens. Both estimates were affected by substantial heterogeneity. Seroprevalence rates for BoDV-1 in children and adolescents suggested that a substantial circulation of the pathogen does occur, and as infants and adolescents have relatively scarce opportunities for being exposed to hosts and animal reservoirs, the potential role of unknown vectors cannot be ruled out.

Keywords